The use of pharmaceutical inhibitor AGI-5198 with IDH mutant patient-derived cultured glioma cells has demonstrated the downregulation of essential epigenetic reader Zinc Finger MYND-Type Containing 8 (ZMYND8) [122]. Here, IDH1 is linked to central nervous system cancer.